TABLE 5.
Effects of flaxseed-oil and fish-oil supplementation on plasma inflammatory markers in women with obesity1
Supplementation with flaxseed oil | Supplementation with DHA-rich fish oil | Pr > F for type 3 fixed effect | |||||
---|---|---|---|---|---|---|---|
D0 | D28 | D0 | D28 | Day | Suppl. | Day*Suppl | |
IFN-γ, pg/mL2,3 | 4.34 ± 2.56 | 4.52 ± 2.80 | 3.79 ± 1.71 | 3.51 ± 1.58 | 0.425 | 0.460 | 0.781 |
IL-10, pg/mL4 | 0.235 ± 0.083 | 0.227 ± 0.081 | 0.231 ± 0.089 | 0.246 ± 0.079 | 0.843 | 0.694 | 0.408 |
IL-1β, pg/mL2,5 | 0.098 ± 0.056 | 0.099 ± 0.047 | 0.092 ± 0.054 | 0.093 ± 0.051 | 0.656 | 0.481 | 0.887 |
IL-6, pg/mL6 | 1.31 ± 1.33 | 1.05 ± 1.08 | 1.07 ± 1.09 | 1.03 ± 1.25 | 0.307 | 0.635 | 0.478 |
IL-8, pg/mL | 2.72 ± 1.17 | 3.26 ± 2.13 | 2.62 ± 1.42 | 2.63 ± 1.37 | 0.278 | 0.393 | 0.250 |
TNF-α, pg/mL2 | 2.01 ± 0.740 | 1.95 ± 0.620 | 1.81 ± 0.500 | 1.90 ± 0.490 | 0.689 | 0.612 | 0.280 |
VEGF, pg/mL2 | 37.8 ± 29.6 | 35.1 ± 23.1 | 39.5 ± 21.5 | 31.3 ± 13.7 | 0.185 | 0.810 | 0.197 |
IL-17A, pg/m2,4 | 0.557 ± 0.278 | 0.491 ± 0.187 | 0.466 ± 0.167 | 0.519 ± 0.146 | 0.956 | 0.834 | 0.026 |
Resistin, pg/m2 | 2530 ± 747 | 2630 ± 712 | 2710 ± 851 | 2560 ± 672 | 0.786 | 0.919 | 0.263 |
Adiponectin, μg/mL | 237 ± 77.1 | 242 ± 83.4 | 237 ± 73.2 | 261 ± 87.97 | 0.010 | 0.903 | 0.079 |
Concentrations are shown as Mean ± SD; n = 19–20 for all markers except VEGF (n = 18–19) and IL-17A (n = 16–19). Differences of least square means and adjusted P-values are in Supplemental Table 7. VEGF, vascular endothelial growth factor.
Log transformed for statistics.
Two outliers removed.
One outlier removed.
Phase order effect (refer to Supplemental Table 1 for values separated by phase).
Indicates residuals distribution may limit validity of the model.
Indicates difference (P < 0.05) from Day 0 of the same phase.